s-block elements |
1 |
Lithium (Li) |
LiC6H7O6
|
Lithium complexes are a good source of antioxidant |
Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors |
[87] |
2 |
C4H6LiNO4
|
Lithium complexes are a good source of antioxidant |
Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors |
[87] |
3 |
Li2CO3
|
Lithium complexes are a good source of antioxidant |
Increases the GABA level which in turn reduces glutamate and downregulates the NMDA receptors |
[87] |
4 |
Calcium (Ca) |
Ca (Cur)2
|
P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus
|
Membrane disruption by inhibiting ATPase activity |
[88] |
p-block elements |
5 |
Gallium (Ga) |
[GaCl2 (4- MepzH)4] GaCl4
|
Effective against HIV |
Fe metabolism |
[84] |
6 |
Tin (Sn) |
Sn (Cur)2
|
Have antifungal potential against P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus
|
Membrane disruption by inhibiting ATPase activity |
[88] |
7 |
Lead (Pb) |
Pb (Cur)2
|
Have antifungal potential against P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus
|
Membrane disruption by inhibiting ATPase activity |
[88] |
d-block elements |
8 |
Cromium (Cr) |
Cr (Curc)3
|
Shows antibacterial activity against E. coli, K. pneumonia, and Pseudomonas sp. |
Membrane disruption by inhibiting ATPase activity |
[88] |
9 |
npapCr |
Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum. Also have antiviral potential against TMV and HSV. |
Cytotoxicity |
[89] |
10 |
Manganese (Mn) |
[MnL] Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes |
[90] |
11 |
Iron (Fe) |
FeCur (OH)2
|
E. coli is the bacterial against which iron complex act |
Membrane disruption by inhibiting ATPase activity |
[88] |
12 |
C18H19ClN3.C5H5.Fe |
Antibacterial against plasmodium falciparum
|
Active against chloroquine-resistant parasitic strains by producing ROS β-lactamase |
[89] |
13 |
npapFe |
Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. |
Cytotoxicity |
[89] |
14 |
[Fe (sulfamethoxazole)2 Cl2].2H2O |
Antibacterial activity against S. aureus, B. subtilis, P. aeruginosa, K. pneumonia, and E. coli
|
Cytotoxicity |
[43] |
15 |
Cobalt (Co) |
[CoCurCl] Cl |
Penicillium digitatum fungi and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against which antimicrobial activity is reported |
Chain breakage |
[88] |
16 |
CoCurCl |
S. aureus, B. subtilis, S. typhi, and E. coli are the bacteria against which cobalt complexes act. |
Membrane disruption by inhibiting ATP-ase activity |
[88] |
17 |
[CoL] Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola are reported |
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes |
[89] |
18 |
Co (sulfamethoxazole)2.3H2O |
Possess antibacterial activity against Mycobacterium tuberculosis
|
Cytotoxicity |
[43] |
19 |
npapCo |
Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. |
Cytotoxicity |
[89] |
20 |
Nickel (Ni) |
[NiCurCl] Cl |
Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against which antimicrobial activity is reported |
Membrane disruption by inhibiting ATPase activity |
[88] |
21 |
NiCurCl |
S. aureus, B. subtilis, S. typhi, P. aeruginosa, and E. coli are the bacteria affected by nickel complexes |
|
[88] |
22 |
npapNi |
Antibacterial activity against P. aeruginosa, E. coli, and S. aureus and antifungal activity against A. flavus, C. albicans, and T. rubrum and also have antiviral potential against TMV and HSV. |
Cytotoxicity |
[89] |
23 |
Ni (sulfamethoxazole)2 Cl].2H2O |
Antibacterial activity against P. aeruginosa, Klebsiella pneumonia, B. subtilis, E. coli, and S. aureus
|
Cytotoxicity |
[43] |
24 |
[NiL] Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and B. subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes |
[89] |
25 |
Copper (Cu) |
[CuCl (H2itsc) (Ph3P)2] 2CH3CN |
Possess antiviral activity and antitumor activity |
Cell death |
[91] |
26 |
C32H16CuN8 |
S. enterica and P. aeruginosa bacteria for which antimicrobial activity was reported |
DNA intercalation |
[92] |
27 |
[Cu (sulfisoxazole)2 (H2O)4] ·2H2O |
E. coli and S. aureus bacteria for which antimicrobial activity was reported |
Inhibiting folic acid synthesis |
[88] |
28 |
[CuCurCl] Cl |
Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus and A. flavus against which antimicrobial activity is reported |
Membrane disruption by inhibiting ATPase activity |
[88] |
29 |
Cu (Cur)2
|
S. aureus, E. coli, Klebsiella pneumonia, and Pseudomonas fluorescence
|
Membrane disruption by inhibiting ATPase activity |
[88] |
30 |
CuCurCl |
S. typhi, P. aeruginosa, and E. coli are effected by copper complexes |
Membrane disruption by inhibiting ATPase activity |
[88] |
31 |
C32H16CuN8 |
Antibacterial activity shown against S. enteric and P. aeruginosa
|
DNA intercalation |
[92] |
32 |
[CuL] Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes |
[93] |
33 |
Cu (sulfisoxazole)2 H2O |
Antibacterial against S. aureus and E. coli
|
Cytotoxicity |
[43] |
34 |
Cu (sulfisoxazole)2 (H2O)2.3H2O |
Antibacterial activity against S. aureus and E. coli
|
Cytotoxicity |
[43] |
35 |
Zinc (Zn) |
[ZnCurCl] Cl |
Penicillium digitatum, fungi, and bacteria such as Streptococcus pyogenes, S. aureus, and A. flavus against antimicrobial activity |
Membrane disruption by inhibiting ATPase activity |
[88] |
36 |
[ZnL] Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataicola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes |
[94] |
37 |
Ruthenium (Ru) |
[Ru (Me4phen)3]2
|
Active against Gram-positive bacteria and Mycobacterium tuberculosis
|
Lipophilicity, charge, and charge separation conducted by Ru |
[72] |
38 |
[Ru (Me4phen)2 (acac)]+
|
Active against Gram-positive bacteria and Mycobacterium tuberculosis
|
Lipophilicity, charge, and charge separation conducted by Ru |
[72] |
39 |
[Ru (2,9-Me2phen)2 (dppz)]2+
|
Active against S. aureus
|
Lipophilicity, charge, and charge separation conducted by Ru |
[72] |
40 |
[Ru (dmob)3]2+
|
Active against S. aureus
|
Lipophilicity, charge, and charge separation conducted by Ru |
[72] |
41 |
([ru (X-phen)2 (acac)]+1
|
Antibacterial activity against Corynebacterium diphtheriae, Mycobacterium tuberculosis, and Staphylococcus aureus
|
Growth inhibition by disturbing biological processes |
[35] |
42 |
Palladium (Pd) |
Pd (Curc)2
|
E. coli and K. pneumonia are the bacteria against which palladium act |
Membrane disruption by inhibiting ATPase activity |
[88] |
43 |
Silver (Ag) |
[HB (3,5- (CF3) 2pz)3] Ag (OSMe2)] |
Have ability against Staphylococcus aureus
|
Cytotoxicity |
[88] |
44 |
Ag (I) carbene |
Antibiotic for E. coli, S. aureus, and P. aeruginosa
|
Eat up bacteria |
[92] |
45 |
Ag (I)–saccharin complex |
Antimicrobial activity against Gram + ve bacteria (Micrococcus luteus and S. aureus) and Gram-negative bacteria (E. coli and, Proteus vulgaris, and P. aeruginosa) |
Eat up bacteria |
[95] |
46 |
Ag (I)-cyclamate |
Antibacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium malmoense, and Mycobacterium kansasii. |
Eat up bacteria |
[96] |
47 |
Ag (I)-aspartame |
Antibacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium malmoense, and Mycobacterium kansasii. |
Eat up bacteria |
[96] |
48 |
[HB (3,5-(CF3) 2pz) 3] Ag (thf)] |
Have ability against Staphylococcus aureus
|
Cytotoxicity |
[24, 97] |
49 |
AgNO3
|
Effective against Ophthalmia neonatorum
|
Binding of free silver ions with tissue proteins, which leads to their precipitation and the obstruction of small vessels |
[24] |
50 |
C10H9AgN4O2S |
Antibacterial activity against Salmonella, E. coli, and S. aureus
|
Cytotoxicity |
[43] |
51 |
Cadmium (Cd) |
Cd (Cur)2
|
Penicillium verruculosum, Aspergillus niger, Aspergillus heteromorphus, Aspergillus flavus, and B. cereus
|
Membrane disruption by inhibiting ATPase activity |
[88] |
52 |
(CdL) Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataicola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhances the penetration of the complexes into lipid membranes |
[98] |
53 |
Mercury (Hg) |
Hg (Cur)2
|
P. verruculosum, A. niger, A. heteromorphus, A. flavus, and B. cereus
|
Membrane disruption by inhibiting ATPase activity |
[88] |
54 |
(HgL) Cl2
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes |
[99] |
55 |
Vanadium (V) |
[VOL] SO4
|
Antibacterial activity against Salmonella typhi, Staphylococcus aureus, Escherichia coli, and Bacillus subtilis and antifungal activity against Aspergillus niger, Aspergillus flavus, and Rhizoctonia bataticola
|
Disturbing respiratory mechanism and blocking metal binding site by delocalization of π-electrons over the whole chelate ring and enhancing the penetration of the complexes into lipid membranes |
[1] |